
BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
German inflation soars to 2.7% in March as Iran war drives up prices - 2
Holiday weather forecast: Where travelers can expect a wintry mix, flooding and record warmth across the U.S. - 3
Why is Jerome Powell being investigated? Making sense of the DOJ's probe into the Federal Reserve chair. - 4
What to know about the "wild, wild West" of viral peptide claims - 5
A definitive Bike Standoff: Decision in favor of Your Number one Ride
Extraordinary Guinness World Records That Will Astound You
Tech Devices 2023: The Most blazing Arrivals of the Year
Merz: 80% of Syrians in Germany expected to return within three years
Artemis II astronauts are more than halfway to the moon as they seek to break Apollo 13's record
The most effective method to Recuperate After a Dental Embed Strategy: A Far reaching Guide
Winter storms blanket the East, while the U.S. West is wondering: Where’s the snow?
Italy Brings In New Measures In 2026 To Tackle Overtourism
Dutch police probe a small blast outside a pro-Israel Christian center
Israel approves 19 new West Bank settlements in major annexation push











